News

The world of Kedrion Biopharma at a glance:
discover the latest
up-to-date news.

All news.
09-01-2023
The Fifth John Gorman Lectureship at the “Birth 2022 Congress”
These Conferences in Transfusion Medicine are made possible thanks to the unconditional support of Kedrion Biopharma
Read all
02-09-2022
Permira Funds and the Marcucci family complete investment in Kedrion & BPL
Announced appointment of Ugo Di Francesco as CEO
Read all
28-06-2022
Kedrion Biopharma Recognized for Innovation in Treating Rare Disease
RYPLAZIM® is the first FDA Approved Treatment for Plasminogen Deficiency Type 1
Read all